Yidian Liu Selected Research

Yidian Liu Research Topics

5	Tuberculosis (Tuberculoses) 12/2023 - 08/2020
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 05/2015 - 01/2013
2	Brain Ischemia (Cerebral Ischemia) 02/2018 - 01/2017
2	Extensively Drug-Resistant Tuberculosis 01/2015 - 04/2011
1	Pulmonary Tuberculosis 08/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2018
1	Reperfusion Injury 02/2018
1	Ischemia 01/2017
1	Infarction (Infarctions) 01/2017
1	Stroke (Strokes) 01/2017
1	Neoplasms (Cancer) 01/2013
1	Mental Disorders (Mental Disorder) 01/2013

2	Clofazimine (Lamprene)FDA Link 12/2023 - 05/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 01/2017
2	Caveolin 1IBA 02/2018 - 01/2017
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2018 - 01/2017
1	Pyrazinamide FDA LinkGeneric 12/2023
1	Ethambutol (Myambutol)FDA LinkGeneric 12/2023
1	Prothionamide (Protionamide)IBA 12/2023
1	GoldIBA 09/2022
1	Interferon-gamma (Interferon, gamma)IBA 06/2021
1	Immunoglobulins (Immunoglobulin)IBA 08/2020
1	Proteins (Proteins, Gene)FDA Link 08/2020
1	AntigensIBA 08/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2020
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Bromodeoxyuridine (BrdU)IBA 01/2017
1	NestinIBA 01/2017
1	Linezolid (Zyvox)FDA Link 01/2015
1	AlbuminsIBA 01/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2013
1	OPC-67683IBA 01/2013
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2011
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2011

2	Retreatment 01/2021 - 01/2013
1	Drug Therapy (Chemotherapy) 01/2015